| Thursday May 8th |
| 17h30 - 20h | Registration |
| 18h - 21h | Welcome dinner (invitation only) |
| Friday May 9th |
| 08h00 - 08h35 | Registration |
| 08h35 - 08h45 | Opening speech |
| Officials from China and the European Union |
| Keynote speeches |
| 08h45 - 09h10 | Impact of the Current Economical & Healcare Reform on the Chinese Pharmaceutical Industry |
| Mr. Yu Mingde, Chairman of the China Pharmaceutical Enterprises Association |
| 09h10 - 09h35 | Assisting European SMEs to Establish Effective Partnership with Local Companies |
| Mr. Frédéric Druck, Vice Chairman of The Council of European BioRegions & Director at BioWin |
| 09h35 - 10h00 | The Market Dynamics and Access: Opportunities and Challenges for European Companies |
| Large Consulting firm (speaker TBC) |
| 10h00 - 10h20 | Tea break & Networking |
| 10h20 - 11h40 | Roadshow (company presentations will be organised by session) |
| Monoclonal antibodies (biopharma) - China |
| Cancer and age-related macular degeration (pharma) - Switzerland |
| Immunotherapy cancer vaccine (pharma) - Israel |
| Oncology, cerebrovascular drugs (pharma) - China |
| Diagnostic and therapeutic use of recombinant allergens (biotech) - Austria |
| 11h40 - 13h00 | Luncheon & Networking |
| Keynote speech |
| 13h00 - 13h15 | Contract Research Organisations' Landscape in China |
| Dr. Jason Liu, Senior VP & COO at Wuxi Apptec |
| 13h15 - 13h30 | Options for Deal Structure with Local Companies |
| Mr. Alan Zhou, Partner at Global Law Office |
| 13h30 - 14h40 | Roadshow (company presentations will be organised by session) |
| Molecular diagnostics in Oncology (diagnostics) - US |
| Respiratory and gastic infectious diseases testing (diagnostics) - Belgium |
| Tumor deep sequencing (diagnostics) - Belgium |
| Mab enhanced production technology (biotech) - Belgium |
| Peptid based products for chronic diseases (biotech) - Austria |
| 14h40 - 15h20 | Panel Discussion |
| Clinical Trial and Regulatory |
| Moderator: | |
| Pannelists: | |
| 15h20 - 15h50 | Coffee break & Networking |
| Keynote speech |
| 15h50 - 16h10 | Key Issues on Market Compliance |
| 16h10 - 16h25 | European Biotech & Pharma Innovation Development |
| Mr. Patrik Frei, Founder and CEO at Venture Valuation |
| 16h25 - 17h10 | Panel Discussion |
| Investment Opportunities in China |
| Moderator: | Ms. Huang Lu, Director at MorningSide Ventures |
| Pannelists: | Dr. Jun Wu, Chairman and Managing Partner at Cenova Ventures |
| | Mr Alan Au, Senior Advisor for Simcere Pharmaceutical Group |
| 17h10 - 17h15 | Closing remarks |
| Mr. Gao Ronghui, CEO of G-med Consulting |
.png)
收藏人
您可能还会关注
会员折扣
该会议支持会员折扣
